Use of appropriate medication regimens, regardless of cost, may help to improve patients’ conditions, improve quality of life, and lower other health care costs.
AMCP supports regulatory and legislative provisions relating to opioid management that ensure appropriate patient access and treatment of uncontrolled pain, while limiting abuse and diversion of opioids and opioid potentiators. .
Presentation developed for AMCP in February 2015
AMCP webinar that discussed the critical role of pharmacists and pharmacies, as there are still many opportunities for pharmacists to be embedded into care teams and help close gaps-in-care.
AMCP webinar that discussed the critical role of pharmacists and pharmacies, as there are still many opportunities for pharmacists to be embedded into care teams and help close gaps-in-care.
AMCP webinar that discussed current ASAM guidelines and other clinical guidance regarding MAT.
AMCP webinar that discussed current ASAM guidelines and other clinical guidance regarding MAT.
AMCP webinar that reviewed the AMCP Addiction Treatment Advisory Group (ATAG) recommendations to improve access to medication-assisted treatment and naloxone.
AMCP webinar that reviewed the AMCP Addiction Treatment Advisory Group (ATAG) recommendations to improve access to medication-assisted treatment and naloxone.
Partnership Forum: Industry experts gathered together July 19-20, 2016 to focus on innovations in diabetes care that are producing changes to treatment options, patient engagement, accountability and patient-provider interactions.
The foundation for the pharmacist’s patient care process is embedded within the pharmaceutical care model developed by Hepler and Strand in the 1990s. However, there is variability in how this process is taught and practiced. To promote consistency across the profession, national pharmacy associations used a consensus-based approach to articulate the patient care process for pharmacists to use as a framework for delivering patient care in any practice setting.
